Switch Therapeutics
Latest round
- Series A
Last raised
- Mar 2023
Total raised
- $36M
Investors
- 10
About Switch Therapeutics
Founded in 2020 by Dee Datta (CEO), and Si-ping Han (CTO), and based in California, US, Switch Therapeutics Inc. is a preclinical stage biotechnology platform that develops medicines aimed to treat diseases of the central nervous system. In March 2023, Switch Therapeutics Inc. The company creates CASi (Conditionally Activated siRNAs), a novel proprietary platform that combines the beneficial traits of single and double-stranded RNAs in a single molecule to aid in the treatment of a variety of illnesses that affect the central nervous system and other organ systems. The company intends to use the March 2023 funds to accelerate its expansion into other disease areas with pharmaceutical company partners.
Who invested in Switch Therapeutics
10 investors across 1 round
See all investors in Switch Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 14, 2023
Amount
$36M
Investors
Questions about Switch Therapeutics
Who invested in Switch Therapeutics?
Switch Therapeutics has 10 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Switch Therapeutics raised?
Switch Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Switch Therapeutics last raise money?
Switch Therapeutics's most recent round on record is a Series A, in Mar 2023.
What does Switch Therapeutics do?
Founded in 2020 by Dee Datta (CEO), and Si-ping Han (CTO), and based in California, US, Switch Therapeutics Inc.
Where is Switch Therapeutics headquartered?
Switch Therapeutics is headquartered in South San Francisco, US.
Which VCs invest in companies like Switch Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Switch Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Switch Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.